The Augustine Therapeutics team wish you a Merry Christmas and a healthy and successful 2024 !!
Augustine Therapeutics’ Post
More Relevant Posts
-
Awakn is dedicated to developing #psychedelic therapeutics for the treatment of #AlcoholUseDisorder, a disorder with a poor current standard of care. Learn about Awakn's unique approach to improving the efficacy and innovation of #AUD treatment here: https://bit.ly/47JaPO3
To view or add a comment, sign in
-
New partnership announcement coming out of CincyTech portfolio company Enable Injections, Inc.! Enable Injections and Serina Therapeutics, Inc. are teaming up to revolutionize Parkinson's Disease treatment. 🧠💉 Their recent agreement aims to develop SER-252 in combination with enFuse, offering advanced solutions for those battling Parkinson's Disease. 🔍 SER-252, coupled with enFuse technology, promises groundbreaking advancements in Parkinson's treatment. With enhanced delivery methods, this collaboration could significantly improve patients' quality of life. Read more about this game-changing partnership here: https://lnkd.in/e4KYSJdZ #ParkinsonsDisease #MedicalInnovation #HealthcareAdvancements
To view or add a comment, sign in
-
-
Today, I am attending Pathways to Access Summit, a pre-ICPR event. Looking forward to learning about perspectives of implementing psychedelic therapeutics into healthcare in Europe! #PathwaysToAccessSummit #ICPR #PsychedelicTherapeutics
To view or add a comment, sign in
-
-
Don't forget to register your attendance to the FREE Webinar with MarketOpen Australia that is being held tomorrow, Wednesday 24th July over Zoom. Dr Liz Dallimore will be providing an update on our Phase 2 clinical trial program. Learn more through the post below ⬇️ #AGN #ASX #stroke #clinicaltrial #strokeawareness #lifescience #investorupdate
Argenica Therapeutics Managing Director and CEO Dr Liz Dallimore will provide an update on the Company's Phase 2 clinical trial program in acute ischaemic stroke on Direct Connect webinar, Wednesday July 24 at 10:30am AWST / 12:30pm AEST. Dr Dallimore will also participate in a Q&A with shareholders post presentation. Registration is FREE and webinar is hosted on ZOOM: https://lnkd.in/gYTigpYF Stewart Walters Holly Walters Amanda Ellis Riley Maring Liddy McCall Bruno Meloni Meghan Thomas Emma Waldon #AGN #ArgenicaTherapeutics #Stroke #Phase2 #ClinicalTrial
To view or add a comment, sign in
-
Headhunting Talented Individuals within Clinical Operations & Clinical Development for growing organizations across the US & Europe
What a super effort from Memo Therapeutics after recently securing their Series B round of funding totalling a whopping $27.67m! 👏💰 This valuable money will be used to begin a clinical trial studying a new treatment approach for preventing infection in kidney transplant patients. 💊 It's very exciting news as there is potential to revolutionize the lives of so many transplant patients around the world🙂🌏 We all like to hear a good news story, right? It always amazes me continually learning of the amazing work that is going on behind the scenes to shape a better future for all - Top work! #MedicineInnovation #Innovation #MemoTherapeutics #ClinicalResearch #ClinicalResearchProfesionals #BetterFuture #Biotechnology #KidneyTransplant #ClinicalTrial #ElixirAssociates
To view or add a comment, sign in
-
Senior Associate Dean for Academic & Student Affairs at USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Many people have seen the Calm app on T.V., but what do you know about the apps that are actually FDA cleared and require a prescription? Here is a brief review of those apps cleared for use in mental health disorders. #digitalhealth #pharmacy #USCMann
Dr. Kari Franson gives a brief overview of the importance of prescription digital therapies (PDTs), including some examples and why these therapies matter for both patients and clinicians. Watch the full presentation for by creating a free guest account! https://lnkd.in/eF-2iBvB Presented at the 2024 NEI Synapse, session titled "A New Script: Implementing Prescription Digital Therapeutics into Practice". Learn about upcoming NEI Meetings: https://lnkd.in/e_359k2J
Prescription Digital Therapies (PDTs)
To view or add a comment, sign in
-
🔊 Are you attending NeurIPS next week? 🤖🧬🖥️ Interested in transforming Drug Disvovery? 📧📝 Connect with our very own Thomas Gaudelet and our Executive Chair Charles Campbell Roberts and find out how we are doing exactly that at Relation Therapeutics #cause2cure #patientiswaiting
To view or add a comment, sign in
-
Did you know that a meniscus tear is one of the most common knee injuries, often resulting from sudden twists or pivots? Finding the right therapy equipment for recovery is crucial. Turn to Gladiator Therapeutics for a non-invasive, drug-free solution and discover why it's trusted by many on their road to recovery. https://ow.ly/Z9s450Sgaqk #GladiatorTherapeutics #Knee #KneePain #KneeInjury #KneeDevice #KneeTherapy #KneeTherapyEquipment
To view or add a comment, sign in
-
-
Rob Etherington, our CEO, discusses innovation, regulatory, and investor challenges and opportunities in the #raredisease therapeutics market with Mike Ward of Clarivate. “We’ve seen regulatory flexibility start to occur for rare diseases and it is a godsend to the patients. More needs to be done… Rare diseases are important fights that we must continue every day,” says Rob. Tune in to hear Rob’s insights on rare disease therapies as Clene Nanomedicine, Inc. works to #EndALS: https://bit.ly/3VO0HQB
To view or add a comment, sign in
-
-
More than 95% of all #rarediseases lack any FDA-approved treatment options, and bringing a drug to market for a #raredisease is an inherently complicated and risky endeavor. That is where pilot programs like the Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program come in, promising to potentially shave off years of the #drugdevelopment pipeline. #FDA announced the first pilot program participants earlier this week, offering much-needed hope to the 7 associated rare disease patient communities - and ultimately to everyone in the rare space who will be able to benefit from the shared learnings. Read the full article here: https://lnkd.in/eeJYSsMA
To view or add a comment, sign in